The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMYRIS INC COM NEW 03236M200   301,170 292,398 SH   SOLE   292,398 0 0
ATRECA INC CL A COM 04965G109   913,179 931,815 SH   SOLE   931,815 0 0
BIONTECH SE SPONSORED ADS 09075V102   16,046,385 148,674 SH   SOLE   148,674 0 0
BUTTERFLY NETWORK INC CL A COM 124155102   2,325,307 1,011,003 SH   SOLE   1,011,003 0 0
CUREVAC N V COM N2451R105   16,942,326 1,625,943 SH   SOLE   1,625,943 0 0
EXSCIENTIA ADS 30223G102   9,418,181 1,590,909 SH   SOLE   1,590,909 0 0
IMMUNCORE HLDGS PLC ADS 45258D105   34,592,303 576,923 SH   SOLE   576,923 0 0
LUMIRADX LTD SHS G5709L109   6,857,143 14,285,714 SH   SOLE   14,285,714 0 0
VIR BIOTECHNOLOGY INC COM 92764N102   38,245,753 1,559,142 SH   SOLE   1,559,142 0 0